JOHNSON & JOHNSON revenue for the last year amounted to 75.10 T CLP, the most of which — 48.29 T CLP — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 44.77 T CLP. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 40.96 T CLP, and the year before that — 41.38 T CLP.